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It is common to perform painful but essential proce-
dures such as wound cleaning, closure of superficial
lacerations, incision of abscesses, nail bed repair and
extraction of foreign bodies for frightened children in
the emergency department (ED). Successful treatment
not only requires cooperation from the child and 
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Thiamylal is widely used for procedural sedation in emergency departments (ED); however,
there are limited safety data for doses of thiamylal > 5 mg/kg in children. We investigated
whether intravenous thiamylal in combination with local anesthetics is safe and effective for
pediatric procedural sedation in the ED and to identify the association between increasing doses
thiamylal and adverse events. Between July 2004 and June 2008, 227 children who underwent
procedural sedation met the inclusion criteria, including 105 males (46.3%) and 122 females
(53.7%). Facial laceration was the most common indication for procedural sedation. All children
received an intravenous injection of thiamylal, with a loading dose of 5 mg/kg. Eighty-one 
children (35.7%) received a supplemental dose of 2.5 mg/kg thiamylal because of inadequate
sedation. Of these, 27 (11.9%) received a second supplemental dose of 2.5 mg/kg because of inad-
equate sedation. Sixty-six patients (29.1%) experienced 75 mild and self-resolving adverse events,
and most of which (15/75; 20%) were drowsiness. Four (1.8%) patients experienced oxygen 
saturation below 96%, which was related to the supplemental dose of thiamylal (p = 0.002). No
children suffered from any lasting or potentially serious complications. Our results indicate that
intravenous thiamylal in combination with local anesthetic infiltration is a well tolerated for ther-
apeutic procedures in the ED. Thiamylal offers rapid onset of sedation without compromising
the patient’s cardiorespiratory function during pediatric procedural sedation.
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parents, but also relies on appropriate pain relief to
reduce discomfort [1,2]. Most children requiring pro-
cedural sedation for therapeutic procedures might
not cooperate with the treatment solely with local
anesthetic administration. To avoid using general
anesthesia and unacceptable delays of initiating treat-
ment when children undergo therapeutic procedures,
pediatric procedural sedation and local anesthesia
provide an alternate method to allow patients to tol-
erate unpleasant procedures and preserve cardiores-
piratory function.
Local anesthetic infiltration can provide excellent
analgesic effects on cooperative children. However, for
most injured young children who do not realize the
benefit of local anesthesia and who suffer from anxiety
and tissue damage-induced pain, they need moderate
to deep sedation for the therapeutic procedures. Agents
such as propofol [3,4], ketamine [5,6], and midazolam
[7] are normally used for procedural sedations. Because
of the different pharmacologic mechanisms of each
drug, there are no criteria to use one drug rather than
another for therapeutic sedation. Barbiturates, which
suppress the transmission of excitatory neurotransmitter
and enhance the transmission of inhibitory neurotrans-
mitters, have been used as monotherapy for procedural
sedation [8–10]. They produce minimal respiratory and
cardiovascular depression. Replacing the sulfur atom
with oxygen at the C2 position of barbiturate acid has
resulted in the development of short-acting barbiturates
such as sodium thiopental and thiamylal, which have
been used successfully as the sole anesthetic for com-
puted tomography/magnetic resonance imaging of
children [11,12].
In the ED, short-acting barbiturates are often used
as the sedative agent in combine with a muscle relax-
ant for rapid intubation [13–16]. Indeed, many studies
have demonstrated the safety and effectiveness of thi-
amylal in the induction of anesthesia. However, there
are limited data in children regarding the induction of
deep sedation and the incidence of adverse events as-
sociated with the use of thiamylal in the ED.
In this study, we used thiamylal, a short-acting bar-
biturate that is structurally similar to but slightly more
potent than thiopental, as an adjuvant to local anes-
thetic infiltration for therapeutic procedures. The objec-
tives of this study were to investigate the effect of
thiamylal for pediatric sedation in the ED and to
identify the association between dose of thiamylal and
incidence of adverse events.
MATERIALS AND METHODS
We conducted a 5-year retrospective observational
study of the use of thiamylal for procedural sedation
in the ED of a large suburban general hospital. This
study was approved by the Institutional Review Board
of Kaohsiung Medical University Hospital. The med-
ical records of 400 patients were reviewed for this
study if they met all of the following criteria: (1)
American Society of Anesthesiologists physical status
of I or II; (2) age between 2 and 7 years old; (3) preop-
erative fasting for more than 6 hours; and (4) under-
going brief sedation with various doses of thiamylal
for a painful procedure between July 2004 to June
2008. Patients were excluded if they had significant
head injuries (unconscious, vomiting, or mentally
obtunded) or wound requiring formal surgical explo-
ration or other injuries requiring admission for fur-
ther care. Patients with known history of a recent
episode of bronchiolitis or bronchial asthma were
also excluded.
The adequacy of sedation was assessed using a 7-
point scale developed and validated at the Children’s
Hospital of Wisconsin [17] (range, 0–6; 0=unresponsive
to painful stimuli; 1=aroused, but not to consciousness,
with painful stimuli; 2 = aroused to consciousness
slowly with sustained painful stimuli; 3 = aroused to
consciousness with moderate tactile or loud verbal
stimuli; 4=drowsy, eyes open or closed, but easily aro-
used to consciousness with verbal stimuli; 5= sponta-
neously awakes without a stimulus; 6 = anxious,
agitated or in pain). In the ED, children planned for
therapeutic painful procedures in a strange environ-
ment do not cooperate with a sedation score of 4. Thus,
adequate sedation was defined as a sedation score of
0–3 and unacceptable sedation was defined as a score
of 4–6. The patient was considered to have recovered
from sedation when his/her vital signs became stable
and consciousness became clear, and when extremity
motility was restored.
Overall, 227 children received an intravenous
bolus of 5 mg/kg thiamylal, which was followed by
local infiltration of 1.5% lidocaine (≤ 3 mg/kg) [18]
when the child lost eyelash reflex. Patients were
divided into three groups [Group S, patients received
an intravenous bolus of 5 mg/kg thiamylal at a regu-
lar rate of 0.5–1.0 mL/sec; Group O, patients received
a supplemental dose of 2.5 mg/kg thiamylal when
sedation was considered inadequate (sedation score
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≥ 4); Group D, patients received a second supplemen-
tal doses of 2.5 mg/kg thiamylal when sedation was
again considered inadequate (sedation score ≥ 4)]
(Figure). An anesthesiologist was consulted when
needed. The ED surgeon was accompanied with staff
with basic training in anesthesiology and advanced
pediatric life support to monitor the patient’s vital
signs when procedural sedation was performed in
this setting. Vital signs, including blood pressure,
electrocardiogram, and pulse oximetry, were routinely
monitored throughout the procedure.
Data including demographic characteristics, wound
type, thiamylal dose, duration of therapeutic proce-
dures, time to discharge, and adverse events were
collected. Time to discharge was defined as the time
from the injection of thiamylal to the patient discharge.
Adverse events including O2 desaturation < 96% with
assisted airway maintenance, hypoxia [oxygen satu-
ration (SaO2) < 90%], apnea (breath holding > 20 sec),
laryngospasm, bronchospasm, cardiovascular insta-
bility, and emergence delirium were considered seri-
ous while nausea, vomiting, and cough, for example,
were considered mild.
Statistical analysis
Demographic data, wound type, thiamylal dose, time
to complete the therapeutic procedure, time to dis-
charge, and adverse events were compared between
the groups using two-sample t tests for continuous
Pediatric patients for therapeutic procedures (n = 227)
Group S (n = 146)
SD score > 4 +
2.5 mg/kg thiamylal
Group O/S
Group D (n = 27)
Data collection
(Assessment of cardiorespiratory function,
adverse effects, time to discharge etc.)  
SD score > 4 +
2.5 mg/kg thiamylal
SD score < 4
SD score < 4
Group O (n = 54)
IV bolus thiamylal (5 mg/kg) +
local anesthetic infiltration
Figure. Experimental setting. Patients were grouped according
to the number of doses of intravenous thiamylal required for pro-
cedural sedation.
variables and χ2 tests for categorical variables or
Fisher’s exact tests for small sample sizes. We per-
formed univariate analysis to identify significant fac-
tors affecting time to discharge and adverse events.
The time to discharge was compared between Groups
O and D using unpaired Student’s t test. Results were
considered statistically significant at p < 0.05.
RESULTS
During the 5-year period, 227 patients underwent
procedural sedation and met the inclusion criteria,
including 105 males (46.3%) and 122 females (53.7%).
As summarized in Table 1, face laceration was the
most common indication for sedation. All children re-
ceived an intravenous injection of thiamylal, with a
loading dose of 5 mg/kg. Of the patients, 81 children
(35.7%) received a supplemental dose of 2.5 mg/kg be-
cause of inadequate sedation and, of these, 27 (11.9%)
received a second supplemental dose of 2.5 mg/kg
because of inadequate sedation.
There were no serious adverse events such as laryn-
gospasm or cardiorespiratory depression. Four epi-
sodes of SaO2 below 96% were recorded; the lowest
SaO2 was 93% (Group S vs. Group O vs. Group D;
p = 0.002). However, all episodes were transient and
recovered to>96% under assisted airway maintenance
by trained medical staff. All four episodes occurred
in the children receiving supplemental doses of 
thiamylal (Group O, n = 1; Group D, n = 3). None of
the children required admission to hospital as a
result of these events. Mild adverse events were
recorded in 26 (11.5%) patients while in the ED, and
in 49 (21.6%) patients after discharge (Table 2). Sixty-
six patients (29.1%) experienced 75 mild and self-
resolving adverse effects, and most of which (15/75;
20%) were drowsiness.
Of the 146 patients in Group S, three (2.1%) devel-
oped nausea, one (0.7%) developed urticaria, three
(2.1%) vomited, four (2.7%) coughed, three (2.1%) men-
tioned pain at the injection site, and four (2.7%) exhib-
ited mild agitation. Among the 54 patients in the
Group O, only one (1.9%) coughed and two (3.7%) ex-
hibited mild agitation. A 6-year-old female experi-
enced a visual hallucination. The child told her parents
she saw something blurred coming out of the wall.
Both she and her parents were not distressed by the
hallucination, and it seemed to resolve quickly.
The average duration of the procedure was 5.38 ±
1.37 minutes for Group S, 6.35 ± 2.04 minutes for
group O, and 9.96±2.90 minutes for Group D. All of 
the children were discharged home and the mean time
to discharge was 40.01 ± 8.41 minutes for Group S,
55.22 ± 13.54 minutes for Group O, and 63.89 ± 17.37
minutes for group D (Table 3). There was a significant
positive correlation between time to discharge and
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Table 2. Treatment-emergent adverse events observed in the emergency department and at home*
Group S (n = 146) Group O (n = 54) Group D (n = 27)
p
ED Home ED Home ED Home
Circulatory depression 0 0 0 0 0 0 1.000
Respiratory depression
Mild (SaO2 < 96%) 0 0 1 0 3 0 0.002†
Severe (SaO2 < 90%) 0 0 0 0 0 0 1.000
Emergence delirium 0 0 0 0 0 0 1.000
Pain at injection site 3 (2.1) 0 0 0 0 0 0.704
Skin rashes 0 5 (3.4) 0 1 (1.9) 0 0 0.569
Urticaria 1 (0.7) 1 (0.7) 0 0 0 1 (3.7) 0.433
Nausea 3 (2.1) 1 (0.7) 0 0 0 0 0.743
Vomiting 3 (2.1) 4 (2.7) 0 1 (1.9) 0 1 (3.7) 0.887
Drowsiness 0 6 (4.1) 0 6 (11.1) 0 3 (11.1) 0.156
Hallucinations 0 0 1 (1.9) 0 0 0 0.352
Agitation 4 (2.7) 5 (3.4) 2 (3.7) 1 (1.9) 1 (3.7) 1 (3.7) 0.950
Cough 4 (2.7) 0 1 (1.9) 1 (1.9) 3 (11.1) 0 0.151
Others 0 9 (6.2) 0 1 (1.9) 0 1 (3.7) 0.477
Total 18 (12.3) 31 (21.2) 4 (7.4) 11 (20.4) 4 (14.8) 7 (25.9) 0.707
*Data presented as n or n (%); †Fisher’s exact test. Group S = 5 mg/kg thiamylal; Group O = 5 mg/kg thiamylal plus one supplemental
dose of 2.5 mg/kg thiamylal; Group D = 5 mg/kg thiamylal plus two supplemental doses of 2.5 mg/kg thiamylal; ED = emergency
department; SaO2 = oxygen saturation.
Table 1. Patient demographic characteristics and wound distribution (n = 227)*
Group S (n = 146) Group O (n = 54) Group D (n = 27)
Age (yr) 3.87 ± 1.34 4.37 ± 1.77 4.41 ± 1.55
Sex, female:male 82:64 23:31 17:10
Weight (kg) 15.92 ± 2.94 17.20 ± 4.31 17.22 ± 3.81
Wound type, lacerations 146 54 27
Chin 22 (15.1) 9 (16.7) 2 (7.4)
Eyebrow 3 (2.1) 7 (13.0) 4 (14.8)
Eyelid 13 (8.9) 2 (3.7) 1 (3.7)
Face 28 (19.2) 5 (9.3) 3 (11.1)
Forehead 44 (30.1) 22 (40.7) 14 (51.9)
Hand 0 1 (1.9) 0
Head 19 (13.1) 5 (9.3) 2 (7.4)
Lip 13 (8.9) 1 (1.9) 1 (3.7)
Nose 4 (2.7) 2 (3.7) 0
*Data presented as mean ± standard deviation, n, or n (%). Group S = 5 mg/kg thiamylal; Group O = 5 mg/kg thiamylal plus one 
supplemental dose of 2.5 mg/kg thiamylal; Group D = 5 mg/kg thiamylal plus two supplemental doses of 2.5 mg/kg thiamylal; 
F = female; M = male.
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increase in thiamylal dose (Group S vs. Group O vs.
Group D: p<0.001; Group O vs. Group D: p=0.029).
DISCUSSION
In this study, we retrospectively reviewed the data for
children sent to our ED, mostly to treat facial lacerations
needing immediate therapeutic procedures. An intra-
venous injection of 5 mg/kg thiamylal for procedural
sedation was insufficient for 35.2% (81/230) of the
children. A supplemental dose (2.5 mg/kg) was
given in 23.5% of patients (i.e. Group O) and a second
supplemental dose was given in 11.7% of patients
(i.e. Group D) to achieve deep sedation. With adequate
cardiorespiratory monitoring and provision of airway
support, as needed, by experts, there were no cases of
circulatory or severe respiratory depression during the
therapeutic procedures, although four patients (1.7%)
experienced O2 desaturation < 96%. No delirium oc-
curred on recovery from sedation either at the ED or at
home. Our study indicated that intravenous thiamylal
was well tolerated and an effective procedural seda-
tion for minor pediatric procedures performed in the
ED. Furthermore, our study also demonstrated the
absence of severe adverse events, although supple-
mental doses of thiamylal were needed to achieve ade-
quate sedation. Unsurprisingly, the time to discharge
from the ED was significantly longer in patients given
repeated doses of thiamylal (p < 0.001).
Scared children suffering from pain, distress, and
anxiety are often unable to calm down in a strange
environment, even if they are accompanied by their
parents. Local analgesia either by a topical anesthetic
or local anesthetic infiltration usually provides suffi-
cient analgesia for facial laceration repair. Once an
intravenous line is placed, sedative agents such as
midazolam, propofol, thiopental, or ketamine can be
used to sedate uncooperative children. However,
propofol causes pain at the injection site and sup-
presses cardiorespiratory function, and ketamine can
induce delirium on recovery, which restrict the use of
these agents in the ED. Parenteral midazolam is a
good option for either diagnostic or therapeutic pro-
cedures. However, as compared with barbiturates, its
slower onset, prolonged duration, rate of failure to
achieve sedation, and potential risk of respiratory
suppression limit the use of midazolam for short, but
painful, therapeutic procedures [19]. Babl et al [20]
reported that high concentrations of nitrous oxide
[(N2O) 70%] are safe for children undergoing proce-
dural sedation and analgesia. However, routine
administration of N2O to children in the ED is not
recommended because it is detrimental to medical
personnel after long-term exposure. This study
revealed that thiamylal provided rapid onset, steady
cardiorespiratory function, and few adverse effects.
In addition, local anesthetic infiltration appears to
provide favorable peri-operative and post-operative
analgesia. Our results demonstrate that intravenous
thiamylal in combination with local anesthetic infil-
tration is well tolerated for therapeutic procedures
and that thiamylal is effective for pediatric pro-
cedural sedation. Our findings also confirm that 
Table 3. Duration of therapeutic procedures and time to discharge from the emergency department*
Group S (n = 146) Group O (n = 54) Group D (n = 27) p
Therapeutic procedure (min) 5.38 ± 1.37 6.35 ± 2.04 9.96 ± 2.90 < 0.001‡
Time to discharge (min)
< 30 1 (0.7) 0 0 1.000
30–40 82 (56.2) 11 (20.4) 4 (14.8) 0.002
41–50 51 (34.9) 10 (18.5) 3 (11.1) 0.048
51–60 8 (5.5) 17 (31.5) 6 (22.2) < 0.001†
61–90 4 (2.7) 16 (29.6) 13 (48.1) < 0.001†
> 90 0 0 1 (3.7) 0.120
Average time spent (min) 40.01 ± 8.41 55.22 ± 13.54 63.89 ± 17.37 < 0.001‡/
0.029§
*Data presented as mean ± standard deviation, n or n (%).†χ2 test; ‡one-way analysis of variance; §unpaired Student’s t test between
Group O and Group D; Group S = 5 mg/kg thiamylal; Group O = 5 mg/kg thiamylal plus one supplemental dose of 2.5 mg/kg 
thiamylal; Group D = 5 mg/kg thiamylal plus two supplemental doses of 2.5 mg/kg thiamylal.
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thiamylal offers an alternate to the conventionally
used sedative agents for therapeutic procedures in
the ED.
One limitation of this study is that an intravenous
access line was needed in all children before the ther-
apeutic procedures could be started. Therefore, we
excluded children in whom intravenous access could
not be prepared because of technical difficulties in in-
serting the access line or because the behavior of the
child prevented insertion of the access line. Some chil-
dren with facial laceration resisted intravenous access
via the forearm or the dorsal hand, even though local
EMLA (Eutectic Mixture of Lidocaine and Prilocaine)
cream was used. In such situations, intramuscular
ketamine was indicated [21]. However, the increased
salivation and delirium on recovery from anesthesia
associated with ketamine is bothersome. Montes and
Bohn [22] reported that the inconvenience associated
with obtaining intravenous access in children was
eliminated by inhaled sevoflurane. However, air pol-
lution of the working environment by volatile anes-
thetics and N2O remains a barrier to their use. In
addition, it is inappropriate to use volatile anesthet-
ics and N2O in a busy ED in which air-conditioning
might not be efficient and waste gas scavengers
might be inadequate because medical personnel
exposed to sevoflurane or N2O may show impaired
judgment and alertness [23,24].
Injured children in the ED, a unique and strange
environment, suffer from wound pain in addition to
varying degrees of anxiety and distress. Thus, the
provision of analgesia by local anesthetic infiltration
alone, without procedural sedation, is generally insuf-
ficient. Intravenous administration of thiamylal can
induce moderate to deep sedation in children. This
study revealed no harmful circulatory or severe res-
piratory suppression during the therapeutic proce-
dures. Therefore, we conclude that intravenous
thiamylal in combination with local anesthetic infil-
tration is a well tolerated modality for therapeutic pro-
cedures performed in the ED.
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Thiamylal 是急診常用於處置過程鎮靜的用藥，惟其較高劑量（> 5mg/kg）用於兒
童的安全性報告有限。本研究的目的為評估於急診使用 thiamylal 作為兒童輕至中度
鎮靜劑的療效與其劑量增加和副作用出現的關連性。回朔性的蒐集由 2004 年 7 月至 
2008 年 6 月的五年內，前往市郊一所教學綜合醫院急診處進行小型侵入性手術的 
227 位病童的資料，本研究評估了靜脈投予 thiamylal，合併使用局部麻醉劑浸潤的
安全性與有效性。105（46%）位男性與 122（54%）位女性病童中，臉部撕裂傷的
侵入性手術處置為使用鎮靜劑的主因。所有的病童都先接受 thiamylal 5mg/kg 作為
初始劑量，其中 81（35.68%）位因鎮靜作用不夠再接受了 thiamylal 2.5 mg/kg的
追加劑量；這 81 位中又有 27（11.89%）位仍因鎮靜作用不夠而再接受了一次 
thiamylal 2.5 mg/kg的追加劑量。結果顯示，66（29.07%）位病童出現了 75 項
輕微且不需緊急處置或用藥的副作用；其中，困倦（20%）為最常出現的副作用。有 
4 位病童曾出現血氧濃度低於 96% 且此與劑量追加有關（p = 0.002），但完全沒有
病童出現嚴重的副作用，亦沒有病童出現嚴重的併發症。這些結果顯示了在急診給予
需要侵入性治療的病童靜脈投予 thiamylal 且合併使用局部麻醉劑浸潤是安全的，
thiamylal 提供了作用迅速與維持平穩心肺功能的優點。
關鍵詞：急診，小兒，處置過程鎮靜，thiamylal
（高雄醫誌 2010;26:192–9）
